Overview
ISO 11135:2014/Amd 1:2018 is an important amendment to the international standard for the sterilization of health-care products using ethylene oxide. This standard outlines the requirements for the development, validation, and routine control of sterilization processes for medical devices. The 2018 amendment specifically revises Annex E, which addresses the single batch release procedure-a critical aspect for sterilizing small quantities such as during product research, development, or clinical trials.
This amendment provides enhanced clarity on the application of sterilization validation methods for single lots, ensuring that medical devices meet strict sterility and safety standards before market release. It helps manufacturers and healthcare providers maintain compliance with international regulations and improve patient safety.
Key Topics
-
Single Batch Release Process
The revision focuses on the robust procedure for releasing products from a single sterilization batch when volumes do not permit multiple sterilization cycles. This includes products in developmental stages or clinical testing.
-
Product Evaluation
Assessment of whether the packaged product can be assigned to an existing product family concerning sterilization characteristics such as composition, design, packaging, biological load, and density.
-
Biological Indicators (BIs) and Dosimeters
Use of biological indicators conforming to ISO 11138-2:2006 to ensure resistance equal to or greater than the product’s natural bioburden, guaranteeing effective sterilization.
-
Testing and Validation Steps
Steps including half-cycle and full-cycle exposure, sterility testing according to ISO 11737-2, and evaluation of ethylene oxide residues to ensure product safety and effectiveness.
-
Documentation and Protocols
Emphasis on detailed documentation of decisions, sample selection, process parameters, and test results, ensuring traceability and compliance.
-
Quality Assurance
Verification of key criteria such as temperature, humidity, sterility, biological challenge equivalency, product functionality, packaging integrity, and biocompatibility after sterilization cycles.
Applications
ISO 11135:2014/Amd 1:2018 applies primarily to:
-
Medical Device Manufacturers
Guiding the sterilization of new or limited-quantity products, particularly for regulatory submissions or clinical trial materials.
-
Quality Control Laboratories
Providing protocols for testing sterilization efficiency, residue levels, and product integrity post-sterilization.
-
Research and Development Teams
Establishing validated sterilization processes for innovative devices and early-stage clinical research products.
-
Healthcare Facilities and Sterilization Services
Offering a compliance framework for ensuring the sterility of ethylene oxide-sterilized health-care products, even in small batches.
This amendment supports maintaining product quality and patient safety by setting clear expectations for single batch sterilization and release.
Related Standards
-
ISO 11138 Series
Biological indicators for sterilization processes, including ISO 11138-2:2006, referenced for biological indicator requirements.
-
ISO 11737 Series
Standards for sterilization microbiology and sterility testing methods applicable in verifying sterility of medical devices.
-
ISO 10993-7
Biological evaluation of medical devices-evaluation of residual ethylene oxide post-sterilization to ensure biocompatibility.
-
ISO 11135:2014
The base standard detailing general requirements for ethylene oxide sterilization processes.
Keywords: ISO 11135:2014, ethylene oxide sterilization, medical device sterilization, single batch release, sterilization validation, biological indicators, routine control, medical device safety, sterility testing, ethylene oxide residue, clinical trial devices, quality assurance in healthcare sterilization.
Open preview (PDF)Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices — Amendment 1: Revision of Annex E, Single batch release